Cited by 426AI in cancer detectionBreast Cancer Treatment StudiesRadiomics and Machine Learning in Medical Imaging

Quantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling

Yuan, Yinyin, Failmezger, Henrik, Rueda, Oscar M., Ali, H. Raza, Gräf, Stefan, Chin, Suet-Feung, Schwarz, Roland F., Curtis, Christina +9 more·2012·Science Translational Medicine

Abstract

Solid tumors are heterogeneous tissues composed of a mixture of cancer and normal cells, which complicates the interpretation of their molecular profiles. Furthermore, tissue architecture is generally not reflected in molecular assays, rendering this rich information underused. To address these challenges, we developed a computational approach based on standard hematoxylin and eosin-stained tissue sections and demonstrated its power in a discovery and validation cohort of 323 and 241 breast tumors, respectively. To deconvolute cellular heterogeneity and detect subtle genomic aberrations, we introduced an algorithm based on tumor cellularity to increase the comparability of copy number profiles between samples. We next devised a predictor for survival in estrogen receptor-negative breast cancer that integrated both image-based and gene expression analyses and significantly outperformed classifiers that use single data types, such as microarray expression signatures. Image processing also allowed us to describe and validate an independent prognostic factor based on quantitative analysis of spatial patterns between stromal cells, which are not detectable by molecular assays. Our quantitative, image-based method could benefit any large-scale cancer study by refining and complementing molecular assays of tumor samples.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.3004330

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Yuan et al. showed that morphological information on TILs combined with gene expression data can significantly improve prognosis prediction for ER-negative breast cancers.

    “For instance, Yuan et al. [251] showed that morphological information on TILs combined with gene expression data can significantly improve prognosis prediction for ER-negative breast cancers while the distribution patterns for TILs and the related genomics information are characterized for multiple cancers in [152].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yuan, Y., Failmezger, H., Rueda, O. M., Ali, H. R., Gräf, S., Chin, S.-F., Schwarz, R. F., Curtis, C., Dunning, M. J., Bardwell, H., Johnson, N., Doyle, S., Turashvili, G., Provenzano, E., Aparicio, S., Caldas, C., & Markowetz, F.
Affiliations
  • University of Cambridge (GB)
  • Center for Integrated Protein Science Munich (DE)
  • University of Southern California (US)
  • Cancer Research UK (GB)
  • Cambridge University Hospitals NHS Foundation Trust (GB)
  • University of British Columbia (CA)
  • Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada.
Corresponding author
  • Yuan, Yinyin
  • Failmezger, Henrik
  • Rueda, Oscar M.
  • Ali, H. Raza
  • Gräf, Stefan
  • Markowetz, Florian
Venue
Science Translational Medicine
Published
2012-10-24
Volume
4
Issue
157
Pages
157ra143-157ra143
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2150461375
Cited by
426
References
2
Citations by year
2026: 11 · 2025: 15 · 2024: 18 · 2023: 40 · 2022: 34 · 2021: 46 · 2020: 38 · 2019: 35 · 2018: 36 · 2017: 44 · 2016: 37 · 2015: 27 · 2014: 25 · 2013: 16 · 2012: 3
FWCI
22.36
Type
journal article
Language
en
Open access
closed
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Cancer Research UK
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
Keywords
breast cancer, H&E staining, tumor cellularity, copy number profiles, estrogen receptor-negative breast cancer, survival prediction, prognostic factors, stromal cells, spatial patterns, image analysis, genomic profiling
MeSH terms
Automation, Breast Neoplasms, Female, Humans, Image Processing, Computer-Assisted, Prognosis, Receptors, Estrogen, Gene Expression Regulation, Neoplastic, Survival Analysis, Lymphocytes, Tumor-Infiltrating, Stromal Cells, Gene Dosage, Gene Expression Profiling, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review